The Clinical Foundation of AIVF

AIVF is a reproductive technology company driving the digital transformation of fertility care. As part of a commitment to scientific discovery, the company conducts clinical research to demonstrate the impact of the technology in clinical settings with partners in Europe, the US, and Asia. The following research using the company’s advanced artificial intelligence technology has been presented at leading international conferences.  

We are proud to present the company’s clinical evidence that has been collected during recent years. One clinical review will be presented each time.

Can EMA, an end-to-end artificial intelligence (AI)-powered platform for fertility clinics, aid in the efficiency of conventional embryo evaluation? An efficiency case study.

Achilleas Papatheodorou (Embryolab Fertility Clinic); Daniella Gilboa (AIVF); Maya Shapiro (AIVF); Chara Oraiopoulou (Embryolab Fertility Clinic;) Mary Karagianni (Embryolab Fertility Clinic); Marianna Papadopoulou (Embryolab Fertility Clinic) ; Daniel Seidman (AIVF)

There is only one thing truly important in the IVF lab and that is accuracy. We work with precious living cells, therefore it takes time to properly evaluate and handle them with the utmost care. In day-to-day operations, the diligent embryologist naturally prioritizes accuracy over efficiency. This study compared the efficiency of embryologists with and without the EMA AI platform. The authors found that the time to evaluate embryos could be significantly reduced by 83% using EMA, and that embryologist agreement with the software was significantly higher than previously reported rates of agreement between embryologists. The use of EMA in clinical practice will optimize the efficiency, productivity, and capacity of the IVF lab. 

To read the abstract, follow the link: https://fertilityconference.org/wp-content/uploads/2023/01/Fertility23_Abstract_book.pdf